Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

7.45
-0.2200-2.87%
Pre-market: 7.450.00000.00%08:30 EDT
Volume:2.40M
Turnover:18.02M
Market Cap:1.36B
PE:-73.04
High:7.89
Open:7.89
Low:7.40
Close:7.67
52wk High:10.08
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:1.37
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-139.54
PE(LYR):2,323.04

Loading ...

Xeris Biopharma is Maintained at Outperform by Leerink Partners

Dow Jones
·
Sep 10

Analysts Conflicted on These Healthcare Names: Xeris Pharmaceuticals (XERS) and Pharvaris (PHVS)

TIPRANKS
·
Sep 10

Xeris Biopharma price target raised to $16 from $12 at Leerink

TIPRANKS
·
Sep 10

Medmix Drug Delivery Unit Partners with Xeris on XP-8121 D-Flex Pen Injector Development

Reuters
·
Sep 10

Xeris Biopharma hosts webinar on XP-8121 development program

TIPRANKS
·
Sep 09

Xeris Targets Phase 3 Start for Once-Weekly Levothyroxine Candidate XP-8121 by Year-End

Reuters
·
Sep 09

Xeris Biopharma CFO Steven Pieper Disposes of 5,000 Shares Worth $42,500

Reuters
·
Sep 02

Xeris to Host XP-8121 Hypothyroidism Program Overview Webinar

Reuters
·
Aug 26

Xeris Biopharma price target raised to $12 from $9 at Barclays

TIPRANKS
·
Aug 20

Why Xeris Biopharma (XERS) Is Up 6.6% After Tighter 2026 Revenue Guidance And Wider Losses

Simply Wall St.
·
Aug 19

Mission Produce And Two Other Stocks Estimated To Be Trading Below Intrinsic Value

Simply Wall St.
·
Aug 14

Xeris Biopharma CFO Steven Pieper Sells 5,000 Shares Worth $42,500

Reuters
·
Aug 13

Xeris Biopharma Holdings, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

UPDATE: Xeris Biopharma Holdings Q2 Adj. EPS $0.00, Inline

Benzinga Earnings
·
Aug 06

Earnings Flash (XERS) Xeris Biopharma Posts Q2 Loss $0.18 a Share

MT Newswires Live
·
Aug 06

Xeris Q2 FY26 Net Loss Widens to $31.1 Million; Revenue Rises 29% to $92.1 Million

Reuters
·
Aug 06

Xeris Biopharma Holdings Q2 EPS $(0.18) Misses $0.00 Estimate, Sales $92.100M Beat $90.225M Estimate

Benzinga Earnings
·
Aug 06

Xeris Biopharma Q2 Net Income USD -31.101 Million

Reuters
·
Aug 06

Xeris Biopharma Q2 EPS USD -0.18

THOMSON REUTERS
·
Aug 06

Xeris Biopharma Outlook Full-Year 2026 Total Revenue Guidance to $385 Million to $390 Million

THOMSON REUTERS
·
Aug 06